Where does Campbell Murray work?

Campbell Murray is at Novartis Venture Fund and Board director at Lighthouse Pharmaceuticals and Board director at TScan Therapeutics and Executive Chairman at Lumos Pharma.

Where did Campbell Murray go to school?

Campbell Murray studied at Harvard Business School (Master of Business Administration (M.B.A.), Management); Kennedy School (Master's Degree, Public Policy); University of Auckland Medical School (Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.), Medicine).

Campbell Murray

Investor

Investor at Novartis Venture Fund · Board director at Lighthouse Pharmaceuticals · Board director at TScan Therapeutics · Executive Chairman at Lumos Pharma

Cambridge, Massachusetts

Kauffman Fellow · Class 11

Find your path to Campbell

1,457 people in our graph share verified history with Campbell — schools, employers, funds. One of them is your warm intro.

David SteinbergunlockedCampbell: together at Carbon Biosciences (2023–2024)

Campbell: together at Agent Capital

Campbell: together at Novartis Venture Fund

×5Campbell: together at Harvard Business School

About

Campbell Murray is a Director at Lighthouse Pharmaceuticals and is affiliated with Double Point Ventures. Murray works in venture capital investment and has experience in the biopharma and life sciences industries.

Board director at Lighthouse Pharmaceuticals

Intro paths

→

In turn, Campbell can intro founders to Lighthouse Pharmaceuticals's investors below.

Lighthouse Pharmaceuticals's investors · 1

Marin Sonoma Impact VenturesCorte Madera · since 2026

Co-founders at Lighthouse Pharmaceuticals

Casey LynchExecutive Officer, Director, Promoter

Board director at TScan Therapeutics

Intro paths

→

In turn, Campbell can intro founders to TScan Therapeutics's investors below.

TScan Therapeutics's investors · 6

6 Dimensions CapitalGrand Cayman · since 2019 Astellas Venture Management LLCSouth San Francisco · $200K – $5M checks Bessemer Venture PartnersRedwood City · $5M – $100M checks Longwood FundBoston · since 2019 PitangoTel Aviv · $4M – $100M checks · since 2021 RA CapitalBoston

Executive Chairman at Lumos Pharma

Intro paths

→

In turn, Campbell can intro founders to Lumos Pharma's investors below.

Lumos Pharma's investors · 6

Clarus VenturesMenlo Park · since 2016 Deerfield Management CompanyNew York · since 2016 New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2016 Sante Health VenturesAustin · since 2014 Sante VenturesAustin · $2M – $6M checks · since 2016 Wellcome TrustLondon · since 2016

Co-founders at Lumos Pharma

Richard John HawkinsExecutive Officer, Director

Experience

Lighthouse PharmaceuticalsDirectorcurrent2026 — present
SynchronDirectorcurrent2025 — presentNew York City Metropolitan Area
Double Point VenturesCo-founder & Managing Partnercurrent2025 — presentBoston, Massachusetts, United States
Double Point VenturesAdvisor2022 — 2025Massachusetts, United States
Lumos PharmaExec. Chair of the Boardcurrent2024 — presentAustin, Texas, United States
Umoja BiopharmaDirectorcurrent2024 — presentSeattle, Washington, United States
ImmunOs Therapeutics AGBoard Observercurrent2024 — present
GEMMA BiotherapeuticsDirectorcurrent2024 — presentPhiladelphia, Pennsylvania, United States
CerevanceDirectorcurrent2024 — presentUnited States
Bioluminescence VenturesSenior Partner2024 — 2025United States
Carbon BiosciencesDirector2023 — 2024United States
Agent CapitalGeneral Partner2023 — 2024Boston, Massachusetts, United States
Diabetes FreePresident & Chief Operating Officer2020 — 2022
Intima BiosciencePresident & Chief Operating Officer2020 — 2022
TigaTxDirector2020Boston, Massachusetts, United States
Renovacor, Inc.Director2019 — 2020United States
TScan TherapeuticsDirector2018 — 2020Greater Boston
Expansion TherapeuticsDirector2018 — 2020San Diego County, California, United States
Lemonaid HealthDirector2017 — 2020San Francisco Bay Area
Novartis Venture FundManaging Director2006 — 2020Cambridge, MA, USA
AnnexonDirector2014 — 2020San Francisco Bay Area

Skills & more

Corporate Venture Capital1Medical DiagnosticsGene TherapyOphthalmologyCell Therapy1Pharmaceutics1Digital HealthBiotechnology58Life Sciences22Venture Capital25Research7Clinical

+8 more

HealthcareStart-upsInvestmentsScienceR&DPharmaceuticalsTherapeuticsBiopharmaceuticals

Languages English

From Campbell's professional profile.

Colleagues at Novartis Venture Fund

Adam Cotton

Principal at the Novartis Venture Fund

Anís

Head of Scoping, Pharma at Deep Science Ventures

Anja Koenig

Global Head of NVF at Novartis Venture Fund

Anja König

Global Head at Novartis Venture Fund

Bart Dzikowski

Managing Director, Head of Transactions & Legal at Novartis Venture Fund

Beat Steffen

Managing Director at Novartis Venture Fund

Christoph Meier

Investor at Novartis Venture Fund

Elaine Jones

Investor at Novartis Venture Fund

Frequently asked questions

Who is Campbell Murray?: Campbell Murray is a Director at Lighthouse Pharmaceuticals and is affiliated with Double Point Ventures. Murray works in venture capital investment and has experience in the biopharma and life sciences industries.
Where does Campbell Murray work?: Campbell Murray is at Novartis Venture Fund and Board director at Lighthouse Pharmaceuticals and Board director at TScan Therapeutics and Executive Chairman at Lumos Pharma.
Where did Campbell Murray go to school?: Campbell Murray studied at Harvard Business School (Master of Business Administration (M.B.A.), Management); Kennedy School (Master's Degree, Public Policy); University of Auckland Medical School (Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.), Medicine).